Asset Details
Do you wish to reserve the book?
Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial
Do you wish to request the book?
Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial
2018
Overview
Background
Few data are available on the long-term effect of pulmonary rehabilitation (PR) and on long PR programs in interstitial lung diseases (ILD).
We aimed to evaluate the effects of PR on exercise capacity (6-Minute Walking Distance, 6MWD; Peak Work Rate, W
max
), quality of life (St George’s Respiratory Questionnaire, SGRQ), quadriceps force (QF) and objectively measured physical activity in ILD after the 6-month PR-program and after 1 year.
Methods
60 patients (64 ± 11 years; 62% males; 23% with IPF) were randomly assigned to receive a 6 month-PR program or usual medical care.
Results
Exercise capacity, quality of life and muscle force increased significantly after the program as compared to control (mean,95%CI[ll to ul]; 6MWD + 72,[36 to 108] m; W
max
19, [8 to 29]%pred; SGRQ − 12,[− 19 to − 6] points; QF 10, [1 to 18] %pred). The gain was sustained after 1 year (6MWD 73,[28 to 118] m; Wmax 23, [10 to 35]%pred; SGRQ − 11,[− 18 to − 4] points; QF 9.5, [1 to 18] %pred). Physical activity did not change.
Conclusions
PR improves exercise tolerance, health status and muscle force in ILD. The benefits are maintained at 1-year follow-up. The intervention did not change physical activity.
Trial registration
Clinicaltrials.gov
NCT00882817
.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Analysis
/ Exercise
/ Exercise Tolerance - physiology
/ Female
/ Humans
/ Lung Diseases, Interstitial - diagnosis
/ Lung Diseases, Interstitial - physiopathology
/ Lung Diseases, Interstitial - rehabilitation
/ Male
/ Medicine
/ Outpatient Clinics, Hospital - trends
